Session 2002-03 15 November 2002
Press Notice 42
TRADE AND INDUSTRY COMMITTEE
COMMITTEE OFFICE HOUSE OF COMMONS 7 MILLBANK LONDON SW1P 3JA
Telephone: 020 7219 5663/5777
Inquiry into the UK Biotechnology Industry
The Trade and Industry Committee announced in March that it would undertake an inquiry to examine the current and future prospects for the UK biotechnology industry, including genomics and related aspects of the pharmaceutical industry. As part of this inquiry, the Committee will take oral evidence on Tuesday 19 November in the Grimond Room, Portcullis House. The witnesses will be:
10.15 Association of the British Pharmaceutical Industry -
Dr Philip Wright, Director of Science and Technology
Dr Alexander Duncan, Executive Vice President of Drug Discovery, Cambridge Antibody Technology
Dr Gill Sanders, Director of Science Policy, Pfizer Central Research
10.55 MRC Laboratory of Molecular Biology, Cambridge -
Dr Greg Winter, CBE, FRS
11.35 University Technology Transfer Units
Dr Jeff Skinner, UCL Ventures
Dr Ederyn Williams, Warwick Ventures
Note to Editors
The Committee is appointed under Standing Order No. 152 of the House of Commons to examine the expenditure, administration and policy of the Department of Trade and Industry and associated public bodies. It has the power to send for persons, papers and records.